The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AIM ImmunoTech Inc(NYSE MKT:AIM) 
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viruses, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for t...
Website: http://www.hemispherx.net
Founded: 1966
Full Time Employees: 24
CEO: Thomas Kenwood Equels
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
AIM ImmunoTech Days Payable Outstanding ttm (DPO)
AIM ImmunoTech Days Receivable Outstanding ttm (DSO)
AIM ImmunoTech Op Cashflow Per Share ttm
AIM ImmunoTech Free Cashflow Per Share ttm
AIM ImmunoTech Cash Per Share ttm
AIM ImmunoTech P/S ratio ttm
AIM ImmunoTech (GAAP) P/E ratio ttm
AIM ImmunoTech P/B ratio ttm
No extra charts and metrics for this ticker.